COMPANY

Xosomix LLC

HQ: San Diego, CA source · xosomix.com ↗ · West Coast

Location: San Diego, CA · source · Oct 13, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $349K (SBIR Phase I 1R43AG102280-01, new, notice Sep 17, 2026). NIH RePORTER 1R43AG102280-01 (Sep 17, 2026)
Evidence (1 event)
- Sep 17, 2026 · NIH RePORTER 1R43AG102280-01
  Organization: XOSOMIX LLC; City/State: SAN DIEGO, CA; Project number: 1R43AG102280-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 349359; Administering IC: National Institute on Aging; Project title: Extracellular Vesicle encapsulated Adeno-associated virus (EV-AAV)-mediated delivery of Neurotrophic factor-α1(NF- α1)/Carboxypeptidase E (CPE) gene (EV-AAV-CPE) as a therapy for Alzheimer's Disease.; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Sep 17, 2026 Grant Government grant — SBIR: $349,359 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NIA. Source: government award database. source ↗

Last 2 years.

Sep 17, 2026 Government grant — SBIR: $349,359 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NIA. Source: government award database. source ↗

Annual award amounts. Total $310K.

Sep 19, 2022 NIH award 1R43HD109099-01A1 FY2022: $309,897 awarded for that fiscal year; activity R43 (SBIR); PI SHARMA, PRANAV; recipient as written: XOSOMIX LLC, SAN DIEGO, CA. Quantitative proteomic profiling of extracellular v source ↗